Reuters: Company News: From prison, 'Pharma Bro' Martin Shkreli sues ex-colleagues for $30 mln

Reuters: Company News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. 
From prison, 'Pharma Bro' Martin Shkreli sues ex-colleagues for $30 mln
May 31st 2019, 21:35

Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, on Friday sued three former colleagues at Retrophin Inc for more than $30 million, saying they illegally ousted him from that company in 2014.

You are receiving this email because you subscribed to this feed at blogtrottr.com. By using Blogtrottr, you agree to our policies, terms and conditions.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions.